References
- Prusiner SB. Prion diseases and the BSE crisis. Science. 1997;278:245–251.10.1126/science.278.5336.245
- Prusiner SB. Prions. Proc. Natl. Acad. Sci. USA. 1998;95:13363–13383.10.1073/pnas.95.23.13363
- Horwich AL, Weissman JS. Deadly conformations – protein misfolding in prion disease. Cell. 1997;89:499–510.10.1016/S0092-8674(00)80232-9
- Prusiner SB. Novel proteinaceous infectious particles cause scrapie. Science. 1982;216:136–144.10.1126/science.6801762
- Arii Y, Oshiro S, Wada K, et al. Production of a recombinant full-length prion protein in a soluble form without refolding or detergents. Biosci. Biotechnol. Biochem. 2011;75:1181–1183.10.1271/bbb.100839
- Benvegnù S, Gasperini L, Legname G. Aged PrP null mice show defective processing of neuregulins in the peripheral nervous system. Mol. Cell. Neurosci. 2011;47:28–35.10.1016/j.mcn.2011.02.005
- Usdin TB, Fischbach GD. Purification and characterization of a polypeptide from chick brain that promotes the accumulation of acetylcholine receptors in chick myotubes. J. Cell. Biol. 1986;103:493–507.10.1083/jcb.103.2.493
- Falls DL, Harris DA, Johnson FA, et al. Mr 42,000 ARIA: a protein that may regulate the accumulation of acetylcholine receptors at developing chick neuromuscular junctions. Cold Spring Harbor Symp. Quant. Biol. 1990;55:397–406.10.1101/SQB.1990.055.01.040
- Harris DA, Falls DL, Johnson FA, et al. A prion-like protein from chicken brain copurifies with an acetylcholine receptor-inducing activity. Proc. Natl. Acad. Sci. USA. 1991;88:7664–7668.10.1073/pnas.88.17.7664
- Peles E, Yarden Y. Neu and its ligands: from an oncogene to neural factors. BioEssays. 1993;15:815–824.10.1002/(ISSN)1521-1878
- Falls DL, Rosen KM, Corfas G, et al. ARIA, a protein that stimulates acetylcholine receptor synthesis, is a member of the neu ligand family. Cell. 1993;72:801–813.10.1016/0092-8674(93)90407-H
- Falls DL. Neuregulins: functions, forms, and signaling strategies. Exp. Cell Res. 2003;284:14–30.10.1016/S0014-4827(02)00102-7
- Fischbach GD, Rosen KM. ARIA: a neuromuscular junction neuregulin. Ann. Rev. Neurosci. 1995;20:429–458.
- Chu GC, Moscoso LM, Sliwkowski MX, et al. Regulation of the acetylcholine receptor ϵ subunit gene by recombinant ARIA: an in vitro model for transynaptic gene regulation. Neuron. 1995;14:329–339.10.1016/0896-6273(95)90289-9
- Moscoso LM, Chu GC, Gautam M, et al. Synapse-Associated Expression of an Acetylcholine Receptor-Inducing Protein, ARIA/Heregulin, and Its Putative Receptors, ErbB2 and ErbB3, in Developing Mammalian Muscle. Dev. Biol. 1995;172:158–169.10.1006/dbio.1995.0012
- Sandrock AW Jr, Goodearl AD, Yin QW, et al. ARIA is concentrated in nerve terminals at neuromuscular junctions and at other synapses. J. Neurosci. 1995;15:6124–6136.
- Wang JY, Miller SJ, Falls DL. The N-terminal region of neuregulin isoforms determines the accumulation of cell surface and released neuregulin ectodomain. J. Biol. Chem. 2001;276:2841–2851.10.1074/jbc.M005700200
- Selvin PR. Fluorescence resonance energy transfer. Methods Enzymol. 1995;246:300–334.10.1016/0076-6879(95)46015-2
- Arii Y, Yamaguchi H, Fukuoka S-I. Production of a soluble recombinant prion protein fused to blue fluorescent protein without refolding or detergents in Escherichia coli cells. Biosci. Biotechnol. Biochem. 2007;71:2511–2514.10.1271/bbb.70303
- Palm GJ, Zdanov GA, Gaitanaris GA, et al. The structural basis for spectral variations in green fluorescent protein. Nat. Struct. Biol. 1997;4:361–365.10.1038/nsb0597-361
- Abràmoff MD, Magalhães PJ, Ram SJ. Image processing with image J. Biophotonics International. 2004;11:36–42.
- Suzuki Y, Yasunaga T, Ohkura R, et al. Swing of the lever arm of a myosin motor at the isomerization and phosphate-release steps. Nature. 1998;396:380–383.
- Suzuki Y. Detection of the swings of the lever arm of a myosin motor by fluorescence resonance energy transfer of green and blue fluorescent proteins. Methods. 2000;22:355–363.10.1006/meth.2000.1087
- Stryer L. Fluorescence energy transfer as a spectroscopic ruler. Ann. Rev. Biochem. 1978;47:819–846.10.1146/annurev.bi.47.070178.004131
- Jones CE, Klewpatonond M, Abdelraheim SR, et al. Probing copper2+ binding to the prion protein using diamagnetic nickel2+ and 1H NMR: the unstructured N terminus facilitates the coordination of six copper2+ ions at physiological concentrations. J. Mol. Biol. 2005;346:1393–1407.
- Riek R, Hornemann S, Winder G, et al. NMR characterization of the full-length recombinant murine prion protein, mPrP(23-231). FEBS Lett. 1997;413:282–288.10.1016/S0014-5793(97)00920-4
- Yarden Y, Sliwkowski MX. Untangling the ErbB signalling network. Nat. Rev. Mol. Cell. Biol. 2001;2:127–137.10.1038/35052073
- Jo SA, Zhu X, Marchionni MA, et al. Neuregulins are concentrated at nerve-muscle synapses and activate ACh-receptor gene expression. Nature. 1995;373:158–161.
- Chang Q, Fischbach GD. An acute effect of neuregulin 1β to suppress α7-containing nicotinic acetylcholine receptors in hippocampal interneurons. J. Neurosci. 2006;26:11295–11303.10.1523/JNEUROSCI.1794-06.2006
- Herndon CA, Fromm L. Neuregulin-1 induces acetylcholine receptor transcription in the absence of GABPα phosphorylation. J. Neurosci. Res. 2008;86:982–991.10.1002/(ISSN)1097-4547
- Belluardo N, Mudò G, Blum M, et al. Central nicotinic receptors, neurotrophic factors and neuroprotection. Behav. Brain Res. 2000;113:21–34.10.1016/S0166-4328(00)00197-2
- Re L, Rossini F, Re F, et al. Prion protein potentiates acetylcholine release at the neuromuscular junction. Pharmacol. Res. 2006;53:62–68.10.1016/j.phrs.2005.09.002
- Heuckeroth RO, Enomoto H, Grider JR, et al. Gene targeting reveals a critical role for neurturin in the development and maintenance of enteric, sensory, and parasympathetic neurons. Neuron. 1999;22:253–263.10.1016/S0896-6273(00)81087-9
- Büeler H, Fischer M, Lang Y, et al. Normal development and behaviour of mice lacking the neuronal cell-surface PrP protein. Nature. 1992;356:577–582.10.1038/356577a0
- Manson JC, Clarke AR, Hooper ML, et al. 129/Ola mice carrying a null mutation in PrP that abolishes mRNA production are developmentally normal. Mol. Neurobiol. 1994;8:121–127.10.1007/BF02780662
- Sakaguchi S, Katamine S, Shigematsu K, et al. Accumulation of proteinase K-resistant prion protein (PrP) is restricted by the expression level of normal PrP mice inoculated with a mouse-adapted strain of the Creutzfelt-Jakob disease agent. J. Viol. 1995;69:7586–7592.
- Sakaguchi S, Katamine S, Nishida N, et al. Loss of cerebellar Purkinje cells in aged mice homozygous for a disrupted PrP gene. Nature. 1996;380:528–531.10.1038/380528a0
- Shmerling D, Hegyi I, Fischer M, et al. Expression of amino-terminally truncated PrP in the mouse leading to ataxia and specific cerebellar lesions. Cell. 1998;93:203–214.10.1016/S0092-8674(00)81572-X
- Takahashi Y, Fukuda Y, Yoshimura J, et al. ERBB4 mutations that disrupt the neuregulin-ErbB4 pathway cause amyotrophic lateral sclerosis type 19. Am. J. Hum. Genet. 2013;93:900–905.
- Gallart-Palau X, Tarabal O, Casanovas A, et al. Neuregulin-1 is concetrated in the postsnaptic subsurface cistern of C-bouton inputs to α-motoneurons and altered during motoneuron diseases. FASEB J. 2014;28:3618–3632.10.1096/fj.13-248583